report banner

News in English

PostNews: Press Release

Big Pharma embraces HoloMonitor technology from PHI

Upon completion of an extensive evaluation in early September one of the top pharmaceutical companies in the world has decided to acquire two HoloMonitor® instruments. The ordered configuration is an automated version of the HoloMonitor platform.
Learn more …
PostNews: Press Release

HoloMonitor technology help researchers fight ovarian cance

Ovarian cancer is one of the deadliest forms of cancer. Researchers at the Center of Excellence for Holographic Imaging at Northeastern University in Boston have used HoloMonitor technology to study how the immune system can be stimulated to fight this deadly cancer form. The research results have been published in Journal of Clinical & Cellular Immunology.
Learn more …
PostPress Release

Phase Holographic Imaging receives first order from United Kingdom after exhibition

Learn more …
PostNews

Florida International University and PHI collaborate to fight cancer

Learn more …
PostNews: Press Release
UCSF Helen Diller Building

PHI provides second HoloMonitor® to University of California, San Francisco to accelerate skin cancer research

PHI has entered into a collaboration agreement with University of California, San Francisco (UCSF) to accelerate ongoing skin cancer research at UCSF.
Learn more …
PostNews

HoloMonitor technology shows versatility as important tool in nanotechnology research

Learn more …
1262728293033